Informazione:
Errore:
ID
34167
Descrizione
Cardiotoxicity of Adjuvant Trastuzumab; ODM derived from: https://clinicaltrials.gov/show/NCT00858039
collegamento
https://clinicaltrials.gov/show/NCT00858039
Keywords
versioni (1)
- 14/01/19 14/01/19 -
Titolare del copyright
see on clinicaltrials.gov
Caricato su
14 gennaio 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Breast Neoplasms NCT00858039
Eligibility Breast Neoplasms NCT00858039
- StudyEvent: Eligibility
Similar models
Eligibility Breast Neoplasms NCT00858039
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
ID.1
Item
female 18 years or older
boolean
ID.2
Item
histologically confirmed, completely excised invasive breast cancer with her-2 overexpression
boolean
ID.3
Item
primary surgery less than twelve weeks prior to registration
boolean
ID.4
Item
lvef>50% as assessed by transthoracic echocardiogram or gated heart pool scan
boolean
ID.5
Item
eastern cooperative oncology group performance status 0-2
boolean
ID.6
Item
adjuvant systemic treatment plan comprises at least three cycles of anthracycline chemotherapy and 52 weeks of trastuzumab
boolean
ID.7
Item
before patient registration, informed consent must be given according to local regulations.
boolean
ID.8
Item
pregnancy
boolean
ID.9
Item
distant metastases from breast cancer
boolean
ID.10
Item
any systemic chemotherapy prior to study entry
boolean